Firm at a glance
Triton Pacific Capital Partners is a private equity firm, per its public portfolio and transaction disclosures [S1].
What they buy
Triton Pacific Capital Partners appears to focus on healthcare services, multi-unit consumer and business services, and specialty finance, based on its publicly disclosed portfolio [S1]. The firm has demonstrated an active add-on acquisition strategy in healthcare, completing four healthcare add-on transactions in the trailing twelve months as of mid-2026 [S2]. The portfolio suggests a preference for platform investments that can be scaled through bolt-on acquisitions, particularly in fragmented healthcare verticals.
Portfolio
Healthcare Services
Triton Pacific holds several healthcare platforms, including Already Autism Health (platform), Integrated Pain Associates (platform), Unio (platform), and DWP [S1]. The firm has actively expanded these platforms through add-on acquisitions in recent quarters.
Multi-Unit Consumer & Business Services
The firm’s Tasty Restaurant Group (platform) operates multiple quick-service restaurant franchise brands, including Tasty King (Burger King), Tasty Hut (Pizza Hut), Tasty Chick’n (KFC), and Tasty Delites (Dunkin’) [S1].
Specialty Finance
Blue Bridge Financial represents the firm’s presence in specialty finance [S1].
Recent activity (last 24 months)
– May 7, 2026: Acquired West Coast Center for Urology (physicians) as an add-on [S2]
– November 17, 2025: Acquired Comprehensive GI Care as an add-on [S2]
– July 8, 2025: Acquired Lubbock Spine Institute as an add-on [S2]
– January 25, 2025: Acquired CABS Autism Services as an add-on [S2]
– January 24, 2025: Acquired Commonwealth ABA as an add-on [S2]
– January 23, 2025: Acquired Already Autism Health [S2]
– June 25, 2024: Exited BioMatrix Specialty Infusion Pharmacy [S2]
How this firm fits a seller
Triton Pacific Capital Partners may appeal to healthcare services businesses seeking a buyer with demonstrated sector expertise and an active buy-and-build approach. The firm’s recent transaction history shows approximately four add-on acquisitions in the trailing twelve months, suggesting an operational model that integrates smaller practices into larger platforms [S2]. The firm has demonstrated exit capability, having divested BioMatrix Specialty Infusion Pharmacy in mid-2024 [S2]. For sellers in multi-unit franchise operations or specialty healthcare, Triton Pacific’s existing platforms may offer strategic fit and integration opportunities.
Sources
[S1] https://tritonpacific.com/portfolio/ (as of 2026-07-20)
[S2] https://tritonpacific.com/news/ (as of 2026-07-20)
Frequently asked questions
Does Triton Pacific Capital Partners buy healthcare services businesses?
Yes, healthcare services represents a significant portion of the firm’s publicly disclosed portfolio [S1]. Triton Pacific has completed multiple healthcare acquisitions in the past 24 months, including the platform acquisition of Already Autism Health and several add-on transactions across urology, gastroenterology, and pain management practices [S2].
What companies has Triton Pacific Capital Partners acquired recently?
Recent acquisitions include West Coast Center for Urology in May 2026, Comprehensive GI Care in November 2025, and Already Autism Health in January 2025 [S2]. The firm has been particularly active in healthcare services, completing approximately four add-on acquisitions in the trailing twelve months.
Where is Triton Pacific Capital Partners based and how big is the firm?
The firm’s headquarters location, fund size, and assets under management were not disclosed in publicly available materials reviewed as of July 2026 [S1][S2].
Is Triton Pacific Capital Partners still actively acquiring?
Yes, the firm appears to be actively acquiring based on recent transaction history. Triton Pacific completed its most recent disclosed acquisition in May 2026 with West Coast Center for Urology [S2], and has maintained a consistent acquisition pace with multiple transactions throughout 2025 and into 2026.
This profile is maintained by CT Acquisitions as an independent third-party reference. CT Acquisitions is not affiliated with, endorsed by, or a representative of the firm profiled. All facts sourced from publicly available materials as of the dates cited.